OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
Tibet Duo Rui Pharmaceutical
301075
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -39.89%1.12B | -17.14%1.64B | -19.39%1.47B | -4.66%1.63B | 4.53%1.86B | 29.49%1.98B | 18.30%1.82B | 31.85%1.71B | 18.34%1.78B | -22.00%1.53B |
Transactional financial assets | ---- | -10.15%125.98M | -78.75%27.13M | -17.33%118.91M | -79.30%37.38M | -53.22%140.2M | -32.15%127.69M | -61.25%143.84M | 413.70%180.58M | --299.73M |
Notes receivable and accounts receivable | 31.02%5.86B | 37.46%5.7B | 25.83%5.49B | 6.41%4.59B | 1.21%4.47B | -2.70%4.15B | -10.08%4.36B | -6.30%4.32B | -2.08%4.42B | -12.68%4.26B |
-Notes receivable | 31.06%1.78B | 58.30%1.77B | -7.19%1.34B | -5.53%1.39B | -19.66%1.36B | -34.27%1.12B | -16.95%1.45B | -6.77%1.47B | 11.33%1.69B | -9.27%1.7B |
-Accounts receivable | 31.00%4.08B | 29.78%3.93B | 42.20%4.15B | 12.60%3.2B | 14.19%3.11B | 18.23%3.03B | -6.23%2.92B | -6.06%2.84B | -8.90%2.72B | -14.81%2.56B |
Other receivables (including interest and dividends) | 14.38%41.07M | 1.71%45.64M | -25.22%32.55M | -7.91%37.22M | -17.93%35.91M | -44.48%44.88M | -51.95%43.53M | 11.99%40.42M | 14.10%43.75M | -8.16%80.83M |
-Other receivable | 14.38%41.07M | ---- | -25.22%32.55M | ---- | -17.93%35.91M | ---- | -51.95%43.53M | ---- | 14.10%43.75M | ---- |
Advance payment | 61.11%144.23M | -16.32%98.25M | 28.16%107.28M | -33.70%71.62M | -3.95%89.53M | 49.46%117.41M | 0.82%83.71M | 3.59%108.03M | 7.11%93.21M | 89.08%78.55M |
Inventories | 11.14%1.78B | 25.14%2.01B | 30.65%1.94B | 9.96%1.73B | 8.21%1.6B | 6.00%1.61B | 4.35%1.49B | -4.35%1.57B | -9.90%1.48B | 5.62%1.52B |
Receivable financing | 28.87%456.16M | 3.11%348.45M | -24.78%345.25M | 24.42%542.77M | 59.40%353.97M | 59.27%337.93M | 47.58%458.96M | 31.50%436.25M | 6.08%222.06M | -34.51%212.18M |
Other current assets | 535.77%412.95M | 34.41%59.33M | 143.62%75.38M | 58.13%71.96M | 60.40%64.95M | 26.21%44.14M | 94.97%30.94M | 28.91%45.51M | -22.52%40.49M | 16.97%34.97M |
Total current assets | 15.23%9.81B | 19.13%10.03B | 12.73%9.49B | 5.05%8.79B | 3.12%8.51B | 5.06%8.42B | -1.04%8.42B | -0.64%8.37B | 2.19%8.26B | -8.53%8.01B |
Non Current assets | ||||||||||
Other non-current financial assets | 0.53%198.53M | -6.78%196.08M | -6.96%198.16M | -3.42%197.33M | 18.47%197.48M | 71.79%210.35M | 70.48%212.99M | 63.29%204.32M | 33.12%166.69M | -5.58%122.44M |
Long-term equity investment | 5.18%425.39M | 0.58%407.71M | 0.27%406.65M | -1.07%402.79M | -0.20%404.45M | -0.22%405.37M | 0.01%405.56M | 92.52%407.15M | 123.37%405.26M | 207.91%406.25M |
Fixed assets | 2.87%1.7B | ---- | 11.95%1.63B | ---- | 16.47%1.65B | ---- | 31.84%1.45B | ---- | 26.56%1.42B | ---- |
Constru in process | -80.66%13.19M | ---- | -57.47%62.27M | ---- | -39.28%68.19M | ---- | -29.37%146.41M | ---- | -11.25%112.3M | ---- |
Intangible assets | -2.20%265.92M | -2.11%267.55M | -1.67%268.65M | -1.66%270.33M | -1.64%271.91M | -1.75%273.31M | 0.46%273.21M | 0.48%274.9M | 0.49%276.44M | 53.42%278.19M |
Goodwill | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M | 0.00%97.44M |
Long deferred expense | -19.96%2.23M | -52.28%1.68M | -56.29%1.73M | -41.90%2.55M | -42.19%2.79M | -21.95%3.51M | -20.00%3.95M | -19.81%4.4M | 19.63%4.83M | --4.5M |
Deferred tax assets | 16.21%92.5M | 2.86%96.52M | 14.80%94.87M | 6.01%80.46M | 1.13%79.6M | 33.61%93.84M | 6.91%82.64M | 3.07%75.9M | 6.06%78.71M | -1.79%70.23M |
Usufruct assets | -0.28%15.69M | -3.54%16.28M | -23.48%13.69M | -22.31%14.74M | -21.20%15.73M | -19.91%16.88M | -18.96%17.89M | -15.77%18.97M | -18.24%19.96M | 57.57%21.08M |
Other non current assets | -28.54%7.83M | 107.88%25.96M | -59.46%30.56M | -88.64%17.81M | -53.51%10.96M | -90.81%12.49M | -4.05%75.37M | 144.49%156.73M | 1.70%23.57M | 18.01%135.82M |
Total non current assets | 0.63%2.82B | 0.88%2.81B | 1.16%2.8B | 2.39%2.79B | 7.56%2.8B | 12.51%2.79B | 15.74%2.77B | 30.84%2.73B | 26.86%2.6B | 32.96%2.48B |
Total assets | 11.61%12.63B | 14.59%12.84B | 9.87%12.29B | 4.39%11.59B | 4.18%11.31B | 6.82%11.21B | 2.64%11.19B | 5.61%11.1B | 7.19%10.86B | -1.25%10.49B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 45.93%3.57B | 57.64%3.79B | 25.74%3.43B | 8.66%2.95B | -2.87%2.44B | -8.66%2.41B | -2.14%2.73B | 8.32%2.71B | 7.52%2.52B | 3.82%2.63B |
Transactional financial liabilities | 1,170.99%2.03M | -99.80%1.5K | --961.48K | ---- | --159.88K | --763.78K | ---- | -89.09%268.25K | ---- | ---- |
Notes payable and accounts payable | -9.69%1.63B | -5.71%1.78B | 8.29%1.65B | 4.46%1.52B | 24.21%1.8B | 55.27%1.88B | 17.75%1.53B | 16.92%1.45B | 18.43%1.45B | -15.51%1.21B |
-Notes payable | -22.30%1.16B | -11.99%1.31B | 3.76%1.16B | 18.87%1.14B | 61.79%1.5B | 80.88%1.49B | 44.61%1.11B | 64.07%957.95M | 31.98%925.07M | -5.37%825.01M |
-Accounts payable | 52.01%464.97M | 18.21%463.49M | 20.60%495.22M | -23.41%379.19M | -41.86%305.88M | 0.91%392.09M | -21.71%410.65M | -24.86%495.12M | 0.32%526.1M | -31.17%388.58M |
Contract liabilities | -24.54%20.22M | -6.09%24.69M | 15.14%28.57M | -37.94%24.18M | -36.78%26.79M | -22.91%26.29M | -27.71%24.82M | -22.00%38.96M | 26.11%42.38M | 14.57%34.11M |
Salaries payable | 6.63%150.5M | 1.41%113.33M | -0.60%108.87M | -9.07%101.31M | -8.60%141.15M | -4.11%111.76M | -2.99%109.53M | 1.57%111.42M | 3.97%154.43M | 6.10%116.54M |
Taxs payable | 40.84%72.14M | 14.17%57.7M | 55.06%73.27M | 26.68%55.44M | 6.27%51.22M | 56.32%50.54M | 15.67%47.25M | -41.17%43.77M | -32.47%48.2M | -48.03%32.33M |
Other payable (including interest and dividends) | 12.79%122.76M | 161.04%110.74M | 140.78%96.8M | 165.20%130.27M | 112.55%108.83M | -59.73%42.42M | -83.37%40.2M | -80.54%49.12M | -84.70%51.2M | 0.31%105.35M |
-Other payable | 12.79%122.76M | ---- | 140.78%96.8M | ---- | 112.55%108.83M | ---- | -83.37%40.2M | ---- | -84.70%51.2M | ---- |
Non current liabilities due within one year | -62.74%96.82M | -46.49%112.77M | 25.47%169.88M | 845.92%275.5M | 342.60%259.84M | 223.00%210.74M | 143.12%135.4M | 17.16%29.13M | 31.93%58.71M | 39.25%65.25M |
Other current liabilities | 20.64%402.83M | 64.19%487.53M | -19.95%375.52M | -27.98%335.42M | -8.14%333.92M | -46.23%296.92M | -25.71%469.1M | -31.03%465.72M | -37.12%363.49M | -31.43%552.23M |
Total current liabilities | 17.28%6.06B | 28.76%6.48B | 16.86%5.94B | 9.86%5.39B | 10.30%5.17B | 5.81%5.03B | -2.32%5.08B | -0.65%4.9B | -1.91%4.69B | -7.50%4.75B |
Current liabilities | ||||||||||
Long term loan | 77.79%278.53M | 29.56%278.59M | 10.00%305.24M | -77.49%76.76M | -26.10%156.66M | 3.40%215.02M | 25.32%277.5M | 108.00%340.93M | 256.98%211.99M | 249.19%207.96M |
Bonds payable | -44.57%264.77M | -17.42%389.66M | 3.42%487.45M | 3.44%481.83M | 3.76%477.64M | 3.77%471.87M | 4.22%471.34M | 4.21%465.81M | 3.87%460.32M | -0.14%454.72M |
Deferred tax liabilities | 58.69%19.86M | -49.89%15.64M | -54.11%14.94M | -54.60%12.55M | -60.12%12.51M | -13.63%31.21M | -11.32%32.55M | -30.30%27.64M | -20.71%31.37M | -7.34%36.13M |
Long term deferred income | -2.91%102.98M | 0.28%120.12M | 30.35%120M | 35.88%123.13M | 14.55%106.07M | 60.76%119.79M | 24.76%92.06M | 27.28%90.62M | 37.68%92.59M | 87.82%74.51M |
Lease liabilities | 18.15%9.16M | 40.64%9.99M | -9.71%6.95M | -17.19%7.6M | -13.32%7.75M | -34.18%7.1M | -32.68%7.7M | -19.21%9.18M | -23.53%8.94M | --10.79M |
Total non current liabilities | -11.22%675.29M | -3.67%813.99M | 6.06%934.57M | -24.87%701.87M | -5.54%760.64M | 7.76%844.98M | 10.75%881.14M | 27.43%934.17M | 29.65%805.22M | 32.10%784.1M |
Total liabilities | 13.63%6.74B | 24.09%7.29B | 15.27%6.87B | 4.30%6.09B | 7.98%5.93B | 6.09%5.87B | -0.58%5.96B | 2.98%5.84B | 1.72%5.49B | -3.40%5.54B |
Shareholders equity | ||||||||||
Paid-in capital | 3.33%2.15B | 1.42%2.11B | 0.02%2.08B | 0.02%2.08B | 0.00%2.08B | 4.18%2.08B | 4.18%2.08B | 4.18%2.08B | 4.18%2.08B | 0.32%2B |
Other equity instruments | -46.45%48.08M | -19.94%71.88M | -0.36%89.47M | -0.35%89.49M | -0.03%89.78M | -0.03%89.78M | -0.02%89.79M | -0.04%89.8M | -0.07%89.81M | -4.43%89.81M |
Capital reserve funds | 62.01%626.63M | 27.62%484.57M | 7.31%398.31M | -3.66%391.68M | -2.51%386.79M | 156.53%379.7M | 150.82%371.19M | 174.90%406.55M | 168.50%396.76M | -23.71%148.01M |
Surplus reserve funds | 14.00%211.44M | 18.60%185.48M | 18.60%185.48M | 18.46%185.48M | 18.46%185.48M | 20.62%156.38M | 20.62%156.38M | 20.76%156.57M | 20.76%156.57M | 22.69%129.65M |
Retained profit | 7.21%2.69B | 6.12%2.57B | 8.96%2.53B | 6.28%2.62B | 6.26%2.51B | 5.88%2.43B | 5.34%2.32B | 12.88%2.47B | 13.51%2.36B | 14.89%2.29B |
Less:Treasury stock | 0.00%66.04M | --66.04M | --66.04M | -40.00%66.04M | -32.90%66.04M | ---- | ---- | --110.07M | --98.42M | ---- |
Other composite income | 17.04%96.84M | -13.19%78.65M | -13.70%83.43M | 28.72%80.79M | 12.91%82.74M | 44.76%90.6M | 107.49%96.68M | 311.26%62.76M | 380.11%73.28M | 139.45%62.59M |
Specific reserves | 3,142.02%397.84K | 14.94%310.65K | 14.51%211.19K | 13.33%111.73K | -3.79%12.27K | 425.24%270.26K | 45.81%184.42K | -8.64%98.59K | -93.13%12.75K | -81.68%51.45K |
Shareholders equity without minority interests | 9.27%5.76B | 4.14%5.44B | 3.62%5.3B | 4.49%5.38B | 4.13%5.27B | 10.70%5.22B | 10.86%5.12B | 12.88%5.15B | 13.45%5.06B | 7.11%4.72B |
Minority interests | 15.21%130.36M | 3.50%114.12M | 7.82%115.76M | 4.87%116.5M | -63.00%113.15M | -53.49%110.26M | -62.39%107.36M | -60.12%111.09M | 13.06%305.85M | -51.49%237.08M |
Total shareholder equity | 9.40%5.89B | 4.12%5.55B | 3.71%5.42B | 4.49%5.5B | 0.30%5.38B | 7.63%5.33B | 6.59%5.22B | 8.68%5.26B | 13.43%5.37B | 1.26%4.95B |
Total liabilityies and equity | 11.61%12.63B | 14.59%12.84B | 9.87%12.29B | 4.39%11.59B | 4.18%11.31B | 6.82%11.21B | 2.64%11.19B | 5.61%11.1B | 7.19%10.86B | -1.25%10.49B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.